机译:脑脊液ABACAVIR浓度在艾滋病毒HIV阳性患者均每日一次施用后
Unit of Infectious Diseases Department of Medical SciencesUniversity of TorinoTorino Italy;
Clinical DepartmentNational Institute for Infectious Diseases “Lazzaro Spallanzani ” Istituto di;
Unit of Infectious Diseases Department of Medical SciencesUniversity of TorinoTorino Italy;
Unit of Infectious Diseases Department of Medical SciencesUniversity of TorinoTorino Italy;
Department of Infectious DiseasesThe Sahlgrenska Academy at University of GothenburgGothenburg;
Clinical DepartmentNational Institute for Infectious Diseases “Lazzaro Spallanzani ” Istituto di;
Unit of Infectious Diseases Department of Medical SciencesUniversity of TorinoTorino Italy;
Clinical DepartmentNational Institute for Infectious Diseases “Lazzaro Spallanzani ” Istituto di;
Unit of Infectious Diseases Department of Medical SciencesUniversity of TorinoTorino Italy;
Clinical DepartmentNational Institute for Infectious Diseases “Lazzaro Spallanzani ” Istituto di;
Unit of Infectious Diseases Department of Medical SciencesUniversity of TorinoTorino Italy;
abacavir; age; central nervous system; cerebrospinal fluid; pharmacokinetics; protease inhibitors;
机译:脑脊液ABACAVIR浓度在艾滋病毒HIV阳性患者均每日一次施用后
机译:脑脊液液体浓度和病毒抑制在HIV-1感染患者中接受Ritonavir-Boosted Atazanavir Plus Lamivudine双抗逆转录病毒治疗(西班牙艾滋病毒/艾滋病研究网络,Prec / Ris 39)
机译:在接受联合治疗的HIV-1感染患者中,脑脊液1型人类免疫缺陷病毒(HIV-1)抑制和依非韦伦药物浓度高。
机译:以前艾滋病病毒抑制患者在替诺福韦加上基于Abacavir的病毒学结果(恢复研究)
机译:阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
机译:每日一次服用HIV阳性患者的脑脊液阿巴卡韦浓度
机译:尽管在接受抗逆转录病毒疗法的HIV-1感染患者中脑脊液HIV RNA未被检测到,但脑脊液趋化因子浓度仍在增加